4.7 Article

Gomisin D alleviates liver fibrosis through targeting PDGFRβ in hepatic stellate cells

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Ginsenoside PPD inhibit the activation of HSCs by directly targeting TGF13R1

Shouli Yuan et al.

Summary: PPD blocks the transmission of the TGF131 pathway, inhibits the activation of HSCs, and has the potential to treat diseases related to the TGF131 signaling pathway.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2022)

Article Oncology

Comparative study of the photo-protective and anti-melanogenic properties of gomisin D, J and O

Joong Suk Jeon et al.

Summary: Skin cancer is a common malignancy and solar ultraviolet radiation plays a crucial role in its development. This study investigated the effects of gomisin D, J, and O on UVA- and UVB-irradiated keratinocytes and alpha-MSH-stimulated melanocytes. The results showed that gomisin D and J improved keratinocyte viability, reduced LDH release, and suppressed ROS production. Gomisin D also inhibited alpha-MSH-induced melanin production and tyrosinase activity in melanocytes. Overall, gomisin D has photoprotective and anti-melanogenic effects.

MOLECULAR MEDICINE REPORTS (2022)

Review Biochemistry & Molecular Biology

PDGF/PDGFR: A Possible Molecular Target in Scleroderma Fibrosis

Chiara Paolini et al.

Summary: Systemic sclerosis is a clinically heterogeneous disorder characterized by vascular alterations, immune/inflammatory manifestations, and organ fibrosis. Despite its complex pathogenesis, recent studies have identified molecular and cellular mediators of SSc fibrosis, potentially leading to targeted therapies.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Pharmacology & Pharmacy

In situ synthesis and unidirectional insertion of membrane proteins in liposome-immobilized silica stationary phase for rapid preparation of microaffinity chromatography

Yanqiu Gu et al.

Summary: Cell membrane affinity chromatography is widely used in membrane protein targeted drug screening and interaction analysis. A novel in situ synthesis membrane protein affinity chromatography method was developed in this study, which achieved efficient in situ synthesis and unidirectional insertion of membrane proteins into liposomes in the stationary phase using cell-free protein expression and covalent immobilized affinity chromatography.

ACTA PHARMACEUTICA SINICA B (2022)

Article Immunology

Modulation of Liver Inflammation and Fibrosis by Interleukin-37

Steffeni Mountford et al.

Summary: Intracellular IL-37 has the potential to downregulate liver inflammation and fibrosis, potentially serving as a novel target for modulating liver fibrosis progression. Serum IL-37 levels show a positive correlation with disease severity in liver cirrhosis, indicating its potential diagnostic and therapeutic utility.

FRONTIERS IN IMMUNOLOGY (2021)

Article Pharmacology & Pharmacy

Dihydromyricetin Reverses Thioacetamide-Induced Liver Fibrosis Through Inhibiting NF-κB-Mediated Inflammation and TGF-β1-Regulated of PI3K/Akt Signaling Pathway

Yingchun Zhao et al.

Summary: The study demonstrated that DHM treatment significantly inhibited liver fibrosis in mice induced by TAA, with decreased ALT and AST activities, increased SOD and GSH levels, and reversed MDA levels. DHM also inhibited hepatocyte apoptosis and hepatic stellate cell activation, and regulated the expression of TGF-beta 1, showing its potential hepatoprotective effects in treating liver fibrosis.

FRONTIERS IN PHARMACOLOGY (2021)

Review Cell Biology

Cellular and Molecular Mechanisms Underlying Liver Fibrosis Regression

Alessandra Caligiuri et al.

Summary: Chronic liver injury can cause hepatic fibrosis and progress to cirrhosis and organ failure. Recent evidence suggests that fibrosis is reversible in the liver due to its regenerative ability, mainly through mechanisms such as removing harmful factors, inactivating myofibroblasts, suppressing inflammation, and degrading extracellular matrix.

CELLS (2021)

Review Health Care Sciences & Services

Traditional Chinese medicine, liver fibrosis, intestinal flora: is there any connection?-a narrative review

Yu-Tong Liu et al.

Summary: This study analyzed the regulation of liver fibrosis pathogenesis by intestinal flora and evaluated the effect of traditional Chinese medicine on the intestinal flora, providing new insights into liver fibrosis treatment. It was found that traditional Chinese medicine can effectively regulate the intestinal flora, aiding in the prevention and treatment of liver fibrosis through the liver-intestine axis. The study highlights the importance of maintaining a healthy intestinal microbiome for liver health and outlines the potential of using traditional Chinese medicine in liver fibrosis prevention and treatment.

ANNALS OF PALLIATIVE MEDICINE (2021)

Review Pharmacology & Pharmacy

Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis

Santosh Kumar et al.

Summary: Non-alcoholic fatty liver disease (NAFLD) is a multifactorial disease with a spectrum of pathological conditions, involving liver cell injury and signaling pathways such as lipotoxicity, oxidative stress, inflammation, etc., ultimately leading to liver regeneration and fibrogenesis. Targeting specific liver cell types using nanotechnology shows potential as a therapeutic strategy for NASH and liver fibrosis.

ADVANCED DRUG DELIVERY REVIEWS (2021)

Article Cell Biology

PDGF-PDGFR network differentially regulates the fate, migration, proliferation, and cell cycle progression of myogenic cells

Osvaldo Contreras et al.

Summary: The study revealed differential expression of PDGF ligands and receptors by myogenic progenitors and muscle stem cells during myogenesis. Adult muscle stem cells and myoblasts preferentially express PDGFRβ over PDGFRα. In myoblasts, PDGF-AB and PDGF-BB treatments activate downstream transducers promoting migration and proliferation, and PDGFRs inhibitor AG1296 inhibits these effects.

CELLULAR SIGNALLING (2021)

Review Immunology

Inflammation as a regulator of hematopoietic stem cell function in disease, and clonal selection

Francisco Caiado et al.

Summary: Inflammation is a defense response to infection or tissue damage involving activation and consumption of immune cells. Hematopoietic stem cells are influenced by inflammatory cues, replacing mature immune cells as needed. Lifelong inflammatory exposure contributes to HSC aging and the selection of premalignant HSC clones.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Review Medicine, General & Internal

Liver cirrhosis

Pere Gines et al.

Summary: Cirrhosis is a widespread disease with various causes, leading to portal hypertension, systemic inflammation, and liver failure. Early diagnosis and management of complications are crucial to prevent progression to decompensated cirrhosis. Liver transplantation may be necessary in severe cases.

LANCET (2021)

Article Gastroenterology & Hepatology

New drugs for NASH

Somaya A. M. Albhaisi et al.

Summary: NASH is a form of liver disease characterized by inflammation and hepatocyte injury in the presence of hepatic steatosis, potentially leading to cirrhosis. Although weight loss and lifestyle modifications are currently the first-line treatment, the development of effective drugs for NASH is urgently needed as these methods may not be effective in advanced cases. There has been significant growth in drug development targeting pathological pathways in NASH in the past decade.

LIVER INTERNATIONAL (2021)

Article Plant Sciences

Activation of AMPK by triptolide alleviates nonalcoholic fatty liver disease by improving hepatic lipid metabolism, inflammation and fibrosis

Rongshuang Huang et al.

Summary: The study shows that low-dose triptolide can alleviate NAFLD-induced hepatic steatosis, inflammation, and fibrosis, while activating AMPK protein to prevent lipogenesis and fibrosis.

PHYTOMEDICINE (2021)

Article Multidisciplinary Sciences

CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells

Yuzo Koda et al.

Summary: The study identified CD8+ tissue-resident memory T cells as key players in resolving liver fibrosis, potentially through Fas-mediated cytotoxicity to eliminate hepatic stellate cells.

NATURE COMMUNICATIONS (2021)

Article Cell Biology

Heterogeneity of Hepatic Stellate Cells in Fibrogenesis of the Liver: Insights from Single-Cell Transcriptomic Analysis in Liver Injury

Wenjun Zhang et al.

Summary: This study identified multiple subpopulations of HSCs and characterized their unique roles and characteristics during liver injury, including differentiating into myofibroblasts and potential involvement in liver regeneration, immune reaction, and vascular remodeling. The scRNA-seq data provided insight into the dynamic transition from HSCs to myofibroblasts in response to liver injury, highlighting the heterogeneity and functional diversity of HSCs. The findings also suggest similarities between the heterogeneity of HSCs in injured mouse livers and cirrhotic human livers.

CELLS (2021)

Review Cell Biology

Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy

Zui Tan et al.

Summary: Liver fibrosis is a result of abnormal wound repair response caused by chronic liver injuries, potentially leading to severe diseases. The detailed mechanism of reversing liver fibrosis is still unclear, posing a challenge in the development of anti-fibrosis drugs.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Gastroenterology & Hepatology

Fatty Acids Activate the Transcriptional Goactivator YAP1 to Promote Liver Fibrosis via p38 Mitogen-Activated Protein Kinase

Shadi Salloum et al.

Summary: This study reveals the significant role of YAP in NAFLD-associated liver fibrosis, with its activation potentially driven by FFA-induced p38 MAPK activation.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Thymosinβ4 alleviates cholestatic liver fibrosis in mice through downregulating PDGF/PDGFR and TGFβ/Smad pathways

Cai Chen et al.

DIGESTIVE AND LIVER DISEASE (2020)

Review Medicine, Research & Experimental

Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review

Anton Gillessen et al.

ADVANCES IN THERAPY (2020)

Review Medicine, Research & Experimental

Mechanisms of liver fibrosis and its role in liver cancer

Debanjan Dhar et al.

EXPERIMENTAL BIOLOGY AND MEDICINE (2020)

Article Gastroenterology & Hepatology

Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis

Jinhang Gao et al.

JOURNAL OF HEPATOLOGY (2020)

Review Cell Biology

Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives

Natascha Roehlen et al.

CELLS (2020)

Article Biochemistry & Molecular Biology

Role of hepatic stellate cell (HSC)-derived cytokines in hepatic inflammation and immunity

Gaurav Gupta et al.

CYTOKINE (2019)

Review Biochemistry & Molecular Biology

ERK Pathway in Activated, Myofibroblast-Like, Hepatic Stellate Cells: A Critical Signaling Crossroad Sustaining Liver Fibrosis

Beatrice Foglia et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Multidisciplinary Sciences

PTP sigma inhibitors promote hematopoietic stem cell regeneration

Yurun Zhang et al.

NATURE COMMUNICATIONS (2019)

Article Medicine, Research & Experimental

Artesunate alleviates liver fibrosis by regulating ferroptosis signaling pathway

Zhaoyan Kong et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

Article Chemistry, Medicinal

Endostatin attenuates PDGF-BB- or TGF-β1-induced HSCs activation via suppressing RhoA/ROCK1 signal pathways

Haitao Ren et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2019)

Review Biochemistry & Molecular Biology

TGF-β and the Tissue Microenvironment: Relevance in Fibrosis and Cancer

Laia Caja et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Review Oncology

PDGF signaling pathway in hepatic fibrosis pathogenesis and therapeutics

Hua-Zhong Ying et al.

MOLECULAR MEDICINE REPORTS (2017)

Review Biochemistry & Molecular Biology

Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years

Alessandro Federico et al.

MOLECULES (2017)

Review Biochemistry & Molecular Biology

The PDGF system and its antagonists in liver fibrosis

Erawan Borkham-Kamphorst et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2016)

Article Toxicology

Mechanisms of CCl4-induced liver fibrosis with combined transcriptomic and proteomic analysis

Shu Dong et al.

JOURNAL OF TOXICOLOGICAL SCIENCES (2016)

Article Gastroenterology & Hepatology

β-PDGF receptor expressed by hepatic stellate cells regulates fibrosis in murine liver injury, but not carcinogenesis

Peri Kocabayoglu et al.

JOURNAL OF HEPATOLOGY (2015)

Article Chemistry, Medicinal

Inhibition of UDP-Glucuronosyltransferases (UGTs) Activity by constituents of Schisandra chinensis

Jin-Hui Song et al.

PHYTOTHERAPY RESEARCH (2015)

Article Gastroenterology & Hepatology

Non-invasive diagnosis of liver fibrosis and cirrhosis

Yoav Lurie et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2015)

Article Pharmacology & Pharmacy

Tracking anti-fibrotic pathways of nilotinib and imatinib in experimentally induced liver fibrosis: An insight

Gamal E. Shiha et al.

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2014)

Article Gastroenterology & Hepatology

Pathogenesis of liver cirrhosis

Wen-Ce Zhou et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Article Medicine, Research & Experimental

MicroRNA-21 activates hepatic stellate cells via PTEN/Akt signaling

Jun Wei et al.

BIOMEDICINE & PHARMACOTHERAPY (2013)

Review Pathology

Pathogenesis of Liver Fibrosis

Virginia Hernandez-Gea et al.

ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)

Article Gastroenterology & Hepatology

New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis

Yan Wang et al.

JOURNAL OF HEPATOLOGY (2010)

Article Plant Sciences

The molecular mechanism of gypenosides-induced G1 growth arrest of rat hepatic stellate cells

Ming-Ho Chen et al.

JOURNAL OF ETHNOPHARMACOLOGY (2008)

Article Gastroenterology & Hepatology

Pro-fibrogenic potential of PDGF-D in liver fibrosis

Erawan Borkham-Kamphorst et al.

JOURNAL OF HEPATOLOGY (2007)

Article Medicine, Research & Experimental

PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTOR

Hongbing Zhang et al.

JOURNAL OF CLINICAL INVESTIGATION (2007)

Article Gastroenterology & Hepatology

PI3K is involved in PDGF-β receptor upregulation post-PDGF-BB treatment in mouse HSC

Carmen G. Lechuga et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)

Article Gastroenterology & Hepatology

Differential expression genes analyzed by cDNA array in the regulation of rat hepatic fibrogenesis

Hui Qiang et al.

LIVER INTERNATIONAL (2006)

Article Gastroenterology & Hepatology

Proteasome inhibition induces hepatic stellate cell apoptosis

A Anan et al.

HEPATOLOGY (2006)

Article Multidisciplinary Sciences

Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma

JS Campbell et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Review Biochemistry & Molecular Biology

Regulation of PDGF and its receptors in fibrotic diseases

JC Bonner

CYTOKINE & GROWTH FACTOR REVIEWS (2004)

Article Cell Biology

p38 MAP kinase mediates platelet-derived growth factor-stimulated migration of hepatic myofibroblasts

P Tangkijvanich et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2002)